Policy Forum

Why FDA Regulation Is a Death Sentence for the Terminally Ill

Date and Time
June 10, 2004 12 - 2 PM EDT
1st floor/Wintergarden

Join the conversation on Twitter using #CatoEvents. Follow @CatoEvents on Twitter to get future event updates, live streams, and videos from the Cato Institute. If you have questions or need assistance registering for the event, please email our staff at events@​cato.​org.

Food and Drug Administration regulations deny terminally ill patients access to experimental drugs that could prolong or save their lives. Charging that this policy “operates as a death sentence for those patients,” the Abigail Alliance for Better Access to Developmental Drugs has filed a citizen petition with — and a lawsuit against — the FDA. A few of the people behind the Abigail Alliance will discuss what it really means to fight for patients’ rights.

Featuring Frank Burroughs, President and Founder, Abigail Alliance; Steve Walker, Regulatory Advisor, Abigail Alliance; and David Price, Counsel, Washington Legal Foundation.